Press Releases Jul 27, 2022 Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress Jul 13, 2022 Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment Jul 11, 2022 Innoviva Completes Acquisition of Entasis Therapeutics View all press releases Presentations & Events View all presentations & events Form 8937 View Form 8937 - September 30, 2015 View Form 8937
Jul 27, 2022 Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
Jul 13, 2022 Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment